OS Fund's book
13 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Numerion Labs | — | $981.0M | — | — | |
| Truvian | — | $329.0M | — | — | |
| NuMat (Specialty Chemicals) | — | $251.0M | — | — | |
| Human Longevity | — | $250.0M | — | — | |
| Elysium Health | — | $240.0M | — | — | |
| Arzeda | — | $149.5M | — | — | |
| Emulate | — | $140.0M | — | — | |
| Lygos | — | $95.0M | — | — | |
| TrueML Technology | — | — | — | — | |
| Kenota Health | Diagnostic Equipment | — | — | — | |
| + 3 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 13 recorded positions
- ·Watchlist + alerts for OS Fund's activity
Create free account
No card required